Direct oral anticoagulants (DOACs) are increasingly encountered in pharmacy practice, for use in patients with atrial fibrillation (AF), and deep vein thrombosis (DVT). As a result, pharmacists are often asked challenging questions regarding the practical management of patients on DOAC therapy. This lesson provides a practical overview to answering these questions, with a focus on
- The role of DOAC therapy in patients with atrial fibrillation (AF) and deep vein thrombosis (DVT)
- Optimizing DOAC therapy according to key patient characteristics
- The pharmacist’s role in assessing, managing, and monitoring patients on DOAC therapy.